Crispina Calsada | CFO |
Jay Hagan | President, CEO & Director |
Denis Drygin | Chief Scientific Officer |
Yanan Zhu | Wells Fargo Securities |
Hello, and welcome to the Regulus Therapeutics Inc. Q3 2022 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to Chief Financial Officer, Cris Calsada. Please go ahead.